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LYSOSTAPHIN: AN ENZYMATIC APPROACH TO STAPHYLOCOCCAL DISEASE.
III. COMBINED LYSOSTAPHIN-METHICILLIN THERAPY OF ESTABLISHED
STAPHYLOCOCCAL ABSCESSES IN MICEt
Serious staphylococcal infections continue to pose therapeutic problems
despite the availability of antimicrobial agents that are effective against
staphylococci in vitro. Much suggests that this relates, in part, to the nature
of the basic lesion in staphylococcal disease. The abscess is the hallmark of
staphylococcal disease, and many therapeutic failures appear to result from
the inability of available antimicrobials to eliminate staphylococci residing
in high titers in abscess lesions. Although antibiotics do penetrate abscess
cavities in high concentrations,' it has been shown that these agents are
relatively ineffective against sluggishly multiplying bacteria found in such
lesions." 8
Lysostaphin is an enzyme containing a peptidase which specifically
cleaves the polyglycine bridges unique to the cell walls of Staphylococcus
aureus."' Previous studies from this laboratory have shown that this agent
kills coagulase-positive staphylococci regardless of their metabolic state.
Further, lysostaphin was highly effective against high titers of coagulase-
positive staphylococci in vitro and in the therapy of experimental staphylo-
coccal lesions in vivo.6"7 These properties suggest that lysostaphin might be
useful in the treatment of serious staphylococcal disease. However, the en-
zyme is a protein with a molecular weight of some 30,000 and its potential
antigenicity has been of concern. Neutralizing and precipitating antibodies
have developed in rabbits given multiple doses of lysostaphin, and ana-
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phylactic reactions have been produced in mice by its repeated administra-
tion.' A therapeutic regimen in which lysostaphin was administered only
once would minimize the dangers of serious hypersensitivity reactions. The
present studies were, therefore, undertaken to evaluate the effectiveness of
a single dose of lysostaphin followed by treatment with methicillin against
established renal abscess lesions in mice.
MATERIALS AND METHODS
The Giorgio strain of Staphylococcus aureus utilized in these studies has been pre-
viously described.8 It is coagulase positive, produces penicillinase, and is inhibited by
3.1 ag/ml. of methicillin in s4tro. Cultures were maintained on trypticase soy agar
slants at 4°C. Eighteen-hour cultures in trypticase soy broth produced 1.4 to 9.7 X
10' viable colony forming units per milliliter and were used in all experiments.
Renal infections were produced in male Swiss albino mice, weighing approximately
20 grams, by injecting the lateral tail veins with 0.2 ml. of the 18-hour culture of the
Giorgio staphylococcus. Kidney staphylococcal titers were determined as previously
described."8 Animals were sacrificed at appropriate intervals and the kidneys were
immediately removed aseptically. tach pair of kidneys was washed under a stream of
sterile distilled water, examined grossly for abscess lesions, and placed in 4 ml. of
sterile physiologic saline in a graduated centrifuge tube. The volume of saline displaced
by the kidneys indicated the volume of kidney tssue from each mouse. The kidneys
were then homogenized in a teflon tissue grinder; homogenates were diluted appropri-
ately, plated in trypticase soy agar, and the number of colony-forming staphylococcal
units per milliliter of kidney tissue was calculated from pour plates. In addition., kid-
neys from all animals dying during the course of infection and random animals sacri-
ficed for kidney titer determinations were streaked on blood agar plates. In all cases,
only coagulase-positive staphylococci were recovered from the infected animals.
Lysostaphin* was diluted in sterile 0.05 M Tris buffer, pH 7.5, which was 0.145 M
with respect to NaCl, to give a concentration of 25 mg/ml. Methicillin was diluted in
sterile distilled water to give a final concentration of 25 mg/ml.
Duncan's new multiple range test was used to analyze the statistical significance of
the results.'
RESULTS
The natural course of the renal infection in mice infected twith the Gior-
gio staphylococcus. Figure 1 shows the natural history of the renal infec-
tion in mice infected with the Giorgio staphylococcus. In this and in
succeeding Figures, each point represents the number of staphylococci per
milliliter of renal tissue of both kidneys removed from a single animal. As
noted, staphylococcal kidney titers rose rapidly and remained remarkably
constant from the fifth day onward. At this time, gross renal abscesses were
present in all animals.'
* Supplied by Dr. Peter Tavormina of the Mead Johnson Research Center, Evans-
ville, Indiana.
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FIG. 1. Staphylococcal kidney titers in untreated mice. The Giorgio staphylococcus
was injected intravenously into test animals.
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FIG. 2. The effect of a single dose of methicillin or lysostaphin on renal staphylococ-
cal populations.
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The effect of a single dose of methicillin or lysostaphin on renal staphyl-
ococcal populations. Figure 2 shows the effect of a single dose of methicillin
or of a single dose of lysostaphin on the staphylococcal populations in these
abscesses. Animals infected five days previously with the Giorgio staphylo-
coccus were either untreated (the control group), were given a single 5
mg. intravenous dose of methicillin, or were given a single 5 mg. intra-
venos dose of lysostaphin. Twenty-four hours later, or on the sixth day of
infection, animals were sacrificed and the kidney titers of staphylococci
determined. As noted, the control animals sacrificed at this time had essen-
tially the same titers as those observed in mice on the day of therapy.
Treatment with methicillin failed to change significantly the titers of
staphylococci in renal abscesses. However, therapy with lysostaphin sig-
nificantly decreased the number of staphylococci present in the renal lesions
(p<O.O1). The mean titer of microorganisms in the lysostaphin-treated
group was reduced by 1.2 log units or by 95 per cent as compared to the
controls.
Long-term effects of a single dose of lysostaphin on renal staphylococcal
populations. As shown in Figure 3, when animals infected five days pre-
viously were treated with a single 5 mg. intravenous dose of lysostaphin
and then followed without further therapy, initial renal titers of staphylo-
cocci in the lysostaphin-treated group were significantly lower than in con-
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FIG. 3. Long-term effects of a single dose of lysostaphin on renal staphylococcal
populations.
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trol animals (p<0.01). However, by the third day after therapy, titers in
the lysostaphin-treated group rose and by the fifth day were not significant-
ly different from those observed in the untreated animals. Thus, a single
dose of lysostaphin only transiently decreased staphylococcal titers within
abscess lesions.
The effect of lysostaphin plus methicillin, or methicillin alone, on renal
staphylococcal populations. The effect of administering multiple doses of
methicillin after a single dose of lysostaphin was then studied. Mice with
established renal abscesses were treated either with an initial single dose
of lysostaphin followed by methicillin, or with multiple doses of methicillin
alone. These results are shown in Figure 4. Mice infected with the Giorgio
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FIG. 4. The effect of lysostaphin plus methicillin, or methicillin alone, on renal
staphylococcal populations.
staphylococcus five days previously were divided into three groups: un-
treated controls; mice receiving a single intravenous dose of 5 mg. of
methicillin on day five, followed by 5 mg. doses of methicillin intramuscu-
larly on the next four succeeding days, days six through nine; and animals
receiving a single 5 mg. dose of lysostaphin intravenously on day five fol-
lowed by 5 mg. of methicillin intramuscularly on the four succeeding days,
days six through nine. On the tenth day after infection, the day following
completion of these treatment schedules, all mice were sacrificed and the
kidney titers of staphylococci determined.
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As noted in Figure 4, the kidney titers in the untreated control mice did
not change significantly from those observed on the day of therapy. Mice
treated with multiple doses of methicillin had decreased renal titers of
staphylococci significant at the 95 per cent confidence level. However, ani-
mals treated with an initial dose of lysostaphin followed by four additional
daily doses of methicillin had greatly reduced renal titers of staphylococci.
These reductions were highly significant when compared with control ani-
mals or when compared with animals treated with methicillin alone
(p<O.Ol). In two cases, no culturable staphylococci could be recovered
from the renal tissues. Mean renal titers of staphylococci in the lysostaphin
plus methicillin-treated group dropped over four log units, a mean reduc-
tion of greater than 99.99 per cent of viable staphylococci.
DISCUSSION
These studies show that staphylococcal populations within established
renal abscesses may be dramatically reduced by treatment with a single
dose of lysostaphin followed by methicillin therapy. This sequential thera-
peutic regimen produced a reduction in microbial titers significantly greater
than that achieved by either lysostaphin or methicillin alone.
The mechanism for the synergism between lysostaphin and methicillin
is not certain. In vitro studies have shown that staphylococci rapidly reach
high titers in artificial media, plateauing at approximately 108 to 109 micro-
organisms per ml.'0 During periods of active growth and metabolism, they
are susceptible to antimicrobial agents such as penecillin,' but appear in-
different to the action of these drugs upon reaching maximal titers. These
microorganisms, at high titers in vitro, are not resistant to antimicrobials
in the usual sense, for reinitiation of growth by environmental manipula-
tion again makes them susceptible to antimicrobial action."'
Experimentally induced staphylococcal disease appears to behave in a
similar manner. During initial stages of infection and vigorous microbial
growth, staphylococci are very sensitive to antibiotics. However, when the
infection reaches the stage of abscess formation, when titers of 109 to 1010
microorganisms per ml. are present,8"' staphylococcal disease is notoriously
refractory to antimicrobial therapy, and eradication frequently requires
surgical drainage of abscess lesions.
Bacteriocidal antimicrobials, such as methicillin, interrupt active cell
wall synthesis. Staphylococci residing in high titers within abscess lesions
may be refractory to these antimicrobial agents because of their sluggish
metabolism.' In contrast, lysostaphin is active against staphylococci in all
stages of growth and metabolic activity. By reducing the number of staphyl-
ococci in these lesions by greater than 90 per cent, this enzyme may allow
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the remaining microorganisms to again become metabolically active and
thus more susceptible to the antimicrobial action of methicillin.
Another explanation for the apparent synergism between lysostaphin
and methicillin is suggested by the studies of lysostaphin-resistant staphyl-
ococcal variants.7"' Microorganisms, selected by exposure of large popula-
tions of staphylococci to lysostaphin, appear to be more susceptible to
penicillin and similar agents. It is therefore conceivable that the staphylo-
cocci remaining in abscess lesions after lysostaphin therapy are more sensi-
tive to methicillin. This possibility is presently under investigation.
SUMMARY
A single dose of lysostaphin, followed by four daily doses of methicillin,
produced striking reductions of titers of staphylococci within established
renal abscesses in mice. These staphylococcal populations were significantly
lower than those in mice treated with five daily doses of methicillin or with
a single dose of lysostaphin. Such a sequential regimen may reduce the
danger of hypersensitivity to lysostaphin and may represent a possible ap-
proach to the management of established life-threatening staphylococcal
disease.
REFERENCES
1. McCune, R.: Delivery of antimicrobial drugs across inflammatory membranes
in rabbits. J. clin. Invest., 1960, 39, 846-853.
2. Werner, V. A., Knight, V., and McDermott, W.: Studies of microbial popula-
tions artificially localized in vivo. I. Multiplication of bacteria and distribu-
tion of drugs in agar loci. J. clin. Invest., 1954, 33, 742-752.
3. Louria, D. B. and Rogers, D. E.: An analysis of the effects of penicillin on an
experimental infection produced by penicillin resistant staphylococci. J. Lab.
clin. Med., 1960, 55, 165-181.
4. Browder, H. P., Zygmunt, W. A., Young, J. R., and Tavormina, P. A.: Lysos-
taphin: Enzymatic mode of action. Biochem. biophys. Res. Commun., 1965,
19, 383-389.
5. Schindler, C. A. and Schuhardt, V. T.: Purification and properties of lysos-
taphin-A lytic agent for Staphylococcus aureus. Biochim. biophys. Acta
(Amst.), 1965, 97, 242-250.
6. Schaffner, W., Melly, M. A., Hash, J. H., and Koenig, M. G.: Lysostaphin: An
enzymatic approach to staphylococcal disease. I. In vitro studies. Yale J.
Biol. Med., 1967, 39, 215-229.
7. Schaffner, W., Melly, M. A., and Koenig, M. G.: Lysostaphin: An enzymatic
approach to staphylococcal disease. II. In zivo studies. Yale J. Biol. Med.,
1967, 39, 230-244.
8. McCune, R. M., Jr., Dineen, P. A. P., and Batten, J. C.: The effect of anti-
microbial drugs on an experimental staphylococcal infection in mice. Ann.
N.Y. Acad. Sci., 1965, 65, 91-102.
9. Steel, R. G. D. and Torrie, J. H.: Principles and Procedures of Statistics. New
York, McGraw-Hill Book Company, Inc., 1960, pp. 107-109.
10. McDermott, W.: Microbial persistence. Yale J. Biol. Med., 1958, 30, 257-291.
11. Rogers, D. E.: Observations on the nature of staphylococcal infections. Bull.
N.Y. Acad. Med., 1959, 35, 25-38.
12. Zygmunt, W. A., Browder, H. P., and Tavormina, P. A.: Lytic action of
lysostaphin on susceptible and resistant strains of Staphylococcus aureus.
Canad. J. Microbiol., 1966, 13, 845-853.
68